评估尿中性粒细胞明胶酶相关脂质运载蛋白对糖尿病肾病的鉴别诊断和进展的影响。
Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
机构信息
Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.
Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.
出版信息
J Diabetes Complications. 2020 Oct;34(10):107665. doi: 10.1016/j.jdiacomp.2020.107665. Epub 2020 Jun 26.
OBJECTIVE
Chronic kidney disease (CKD) related to diabetes has become more common than glomerulonephritis in recent years. Given the inefficient and difficult identification of diabetic kidney disease (DKD) from non-diabetic kidney disease (NDKD) as well as a result of emerging evidence supporting a role for tubular involvement in DKD, we aimed to investigate the utility of urinary neutrophil gelatinase-associated lipocalin (uNGAL) in the differential diagnosis and predictive value of DKD from NDKD.
METHODS
Data for 100 type 2 diabetic patients with CKD at our center from June 2016 to August 2019 were reviewed. All the patients were categorized into 2 groups by the renal biopsy results: DKD and NDKD. Urinary NGAL levels were normalized by urinary creatinine and calculated as uNGAL/creatinine ratios (uNCR). The independent factors of the occurrence of DKD and the diagnostic implications of uNCR were explored by logistic regression and receiver-operating characteristic (ROC) curve analysis. In addition, we analyzed the relationship between uNCR and proteinuria in patients with DKD by Pearson test and linear regression. Kaplan-Meier survival analysis was performed to assess the prospective association of uNCR with the renal outcome.
RESULTS
Significantly higher levels of uNCR were observed in patients with DKD when compared to those with NDKD (28.65 ng/mg vs 27.47 ng/mg, p< .001). uNCR was identified as an independent risk factor for the occurrence of DKD in diabetic patients with CKD (odds ratio [OR] = 1.020; 95%CI = [1.001-1.399], p = .042). The optimal cutoff value of uNCR for predicting DKD was 60.685 ng/mg with high specificity (90.5%) but relatively low sensitivity (55.7%). In Pearson test, uNCR was positively correlated with proteinuria, serum creatine, blood urea nitrogen, duration of diabetes, interstitial inflammation score and global sclerosis, whereas it was inversely correlated with eGFR, hemoglobin, serum albumin and 25-hydroxy vitamin D. Furthermore, in a fully adjusted model including eGFR, serum albumin and total cholesterol, the group with uNCR>60.685 ng/mg was associated with 7.595 times higher likelihood of nephrotic-range proteinuria compared to the group with uNCR≤60.685 ng/mg. In the Kaplan-Meier survival analysis, the event-free survival probability in patients with uNCR>60.685 ng/mg was significantly lower than those with uNCR≤60.685 ng/mg (p = .048).
CONCLUSIONS
uNCR might serve as a potential tool for identifying cases in which there was a high clinical suspicion of DKD and that in whom confirmatory biopsy could be considered, and the best predictive cutoff value of normalized uNCR for DKD diagnosis was 60.685 ng/mg. Type 2 diabetic patients with increased level of uNCR had higher risk to nephrotic-range proteinuria and worse renal outcome.
目的
近年来,与糖尿病相关的慢性肾脏病(CKD)比肾小球肾炎更为常见。鉴于从非糖尿病性肾脏病(NDKD)中难以有效且困难地识别糖尿病肾病(DKD),以及新兴证据支持管腔参与 DKD 的作用,我们旨在研究尿中性粒细胞明胶酶相关脂质运载蛋白(uNGAL)在 DKD 与 NDKD 鉴别诊断和预测价值中的作用。
方法
回顾了 2016 年 6 月至 2019 年 8 月期间我院收治的 100 例 2 型糖尿病伴 CKD 患者的数据。所有患者均根据肾活检结果分为 2 组:DKD 和 NDKD。尿 NGAL 水平通过尿肌酐进行标准化,并计算为 uNGAL/肌酐比值(uNCR)。通过逻辑回归和受试者工作特征(ROC)曲线分析探讨了 DKD 发生的独立因素和 uNCR 的诊断意义。此外,我们通过 Pearson 检验和线性回归分析了 DKD 患者 uNCR 与蛋白尿之间的关系。Kaplan-Meier 生存分析用于评估 uNCR 与肾脏预后的前瞻性关联。
结果
与 NDKD 患者相比,DKD 患者的 uNCR 水平显著升高(28.65 ng/mg 比 27.47 ng/mg,p<.001)。uNCR 是糖尿病合并 CKD 患者发生 DKD 的独立危险因素(比值比[OR] = 1.020;95%CI = [1.001-1.399],p =.042)。预测 DKD 的最佳 uNCR 截断值为 60.685 ng/mg,特异性高(90.5%),但敏感性相对较低(55.7%)。在 Pearson 检验中,uNCR 与蛋白尿、血清肌酐、血尿素氮、糖尿病病程、间质炎症评分和全球硬化呈正相关,与 eGFR、血红蛋白、血清白蛋白和 25-羟维生素 D 呈负相关。此外,在包括 eGFR、血清白蛋白和总胆固醇在内的完全调整模型中,uNCR>60.685 ng/mg 的组发生肾病范围蛋白尿的可能性是 uNCR≤60.685 ng/mg 的组的 7.595 倍。在 Kaplan-Meier 生存分析中,uNCR>60.685 ng/mg 组的无事件生存概率明显低于 uNCR≤60.685 ng/mg 组(p =.048)。
结论
uNCR 可能是一种潜在的工具,可用于识别临床高度怀疑 DKD 且需要确认活检的患者,uNCR 用于 DKD 诊断的最佳预测截断值为 60.685 ng/mg。uNCR 水平升高的 2 型糖尿病患者发生肾病范围蛋白尿和肾脏预后不良的风险更高。